Evidence map›Paper›PMID 18803320›Full record

ReviewGlia2008

The function of RhoGTPases in axon ensheathment and myelination.

M Laura Feltri, Ueli Suter, João B Relvas

Open access · bronzeAbstract readReview
In one paragraph

Review in Glia, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Myelin Biology.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Rho GTPases as therapeutic targets in cancer (Review).International journal of oncology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

M Laura FeltriDIBIT, San Raffaele Scientific Institute, Milano, Italy.
Ueli SuterInstitute of Cell Biology, Department of Biology, Eidgenössische Technische Hochschule Zurich, CH-8093 Zurich, Switzerland.
João B RelvasInstitute of Cell Biology, Department of Biology, Eidgenössische Technische Hochschule Zurich, CH-8093 Zurich, Switzerland.
ETH Zurich · CH

Funding

Laminin Receptors and Signals in Schwann CellsR01NS045630 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SIM, FRASER JAMES · 2003 to 2024
$5.9M
NINDS NIH HHS R01 NS045630Telethon GGP08021
6 · The paper itself

Abstract

RhoGTPases are molecular switches that integrate extracellular signals to perform diverse cellular responses. This ability relies on the network of proteins regulating RhoGTPases activity and localization, and on the interaction of RhoGTPases with many different cellular effectors. Myelination is an ideal place for RhoGTPases regulation, as it is the result of fine orchestration of many stimuli from at least two cell types. Recent work has revealed that RhoGTPases are required for Schwann cells to sort, ensheath, and myelinate axons. Here, we will review these recent advances showing the critical roles for RhoGTPases in various aspects of Schwann development and myelination, including the recent discovery of their involvement in Charcot-Marie-Tooth disease. Comparison with potential roles of RhoGTPases in central nervous system myelination will be drawn.

Indexed as

AnimalsAxonsCell DifferentiationCentral Nervous SystemGene Expression Regulation, DevelopmentalHumansMyelin SheathNerve Fibers, MyelinatedPeripheral Nervous Systemrho GTP-Binding ProteinsSchwann Cellsrho GTP-Binding Proteins

Identifiers

PMID18803320
PMCPMC2615182
OpenAlexW2068855741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.